Drugs / BI 113823
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01207973 | Sep 2010 → Jan 2011 | osteoarthritis, knee | Boehringer Ingelheim | Terminated | No outcome recorded |
| Phase 1 | NCT01189175 | Aug → Sep 2010 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02259972 | Jan → Jun 2010 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 113823 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01189175 ↗ |
| Route | Oral | “Single Oral Dose of BI 113823” NCT01189175 ↗ |